LONDON, April 22, 2015 /PRNewswire/ -- In 2014, the market for infusion therapy devices included infusion pumps, intravenous (IV) sets and needleless connectors (NLCs). These three broad categories are further segmented based on specific distinguishing categories. The segmentation for the needleless connector market is based on the different types of displacement available, such as positive, negative and neutral. The infusion pump market is segmented in categories based on the type of infusion performed, such large volume, syringe, electronic ambulatory and disposable infusion pumps. Finally, the intravenous set market is segmented by tubing type, such as primary IV, secondary IV and IV extension sets.
In 2014, the total European market for infusion therapy devices was valued at close to €900 million. This market comprises a mixture of capital equipment and one-time use disposables, including large volume, syringe, electronic ambulatory, and disposable ambulatory infusion pumps; intravenous (IV) sets; and needleless connectors (NLCs).
While all segments of the European infusion therapy device market are expected to experience ASP erosion over the forecast period, these segments will grow corresponding to two factors driving unit sales: the increasing elderly patient population in Europe, and a subsequent increase in diseases that require infusion therapy device treatment.
Download the full report: https://www.reportbuyer.com/product/2861363/
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers